Global Infantile Spasms Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 85

Published Date: 04 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Infantile Spasms Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Infantile Spasms Therapeutics market size is estimated to be worth US$ 146.1 million in 2021 and is forecast to a readjusted size of USD 185.2 million by 2028 with a CAGR of 3.4% during review period. Hospital accounting for  % of the Infantile Spasms Therapeutics global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Oral segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Infantile Spasms Therapeutics include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, and Valerion Therapeutics, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Infantile Spasms Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral
    Injection

Market segment by Application, can be divided into
    Hospital
    Clinic
    Other

Market segment by players, this report covers
    Mallinckrodt
    H. Lundbeck
    Insys Therapeutics
    Orphelia Pharma
    Valerion Therapeutics
    Catalyst Pharmaceuticals
    Anavex Life Sciences
    Retrophin
    GW Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Infantile Spasms Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Infantile Spasms Therapeutics, with revenue, gross margin and global market share of Infantile Spasms Therapeutics from 2019 to 2022.
Chapter 3, the Infantile Spasms Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Infantile Spasms Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Infantile Spasms Therapeutics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infantile Spasms Therapeutics
    1.2 Classification of Infantile Spasms Therapeutics by Type
        1.2.1 Overview: Global Infantile Spasms Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Infantile Spasms Therapeutics Revenue Market Share by Type in 2021
        1.2.3 Oral
        1.2.4 Injection
    1.3 Global Infantile Spasms Therapeutics Market by Application
        1.3.1 Overview: Global Infantile Spasms Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Global Infantile Spasms Therapeutics Market Size & Forecast
    1.5 Global Infantile Spasms Therapeutics Market Size and Forecast by Region
        1.5.1 Global Infantile Spasms Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Infantile Spasms Therapeutics Market Size by Region, (2017-2022)
        1.5.3 North America Infantile Spasms Therapeutics Market Size and Prospect (2017-2028)
        1.5.4 Europe Infantile Spasms Therapeutics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Infantile Spasms Therapeutics Market Size and Prospect (2017-2028)
        1.5.6 South America Infantile Spasms Therapeutics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Infantile Spasms Therapeutics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Infantile Spasms Therapeutics Market Drivers
        1.6.2 Infantile Spasms Therapeutics Market Restraints
        1.6.3 Infantile Spasms Therapeutics Trends Analysis

2 Company Profiles
    2.1 Mallinckrodt
        2.1.1 Mallinckrodt Details
        2.1.2 Mallinckrodt Major Business
        2.1.3 Mallinckrodt Infantile Spasms Therapeutics Product and Solutions
        2.1.4 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Mallinckrodt Recent Developments and Future Plans
    2.2 H. Lundbeck
        2.2.1 H. Lundbeck Details
        2.2.2 H. Lundbeck Major Business
        2.2.3 H. Lundbeck Infantile Spasms Therapeutics Product and Solutions
        2.2.4 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 H. Lundbeck Recent Developments and Future Plans
    2.3 Insys Therapeutics
        2.3.1 Insys Therapeutics Details
        2.3.2 Insys Therapeutics Major Business
        2.3.3 Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions
        2.3.4 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Insys Therapeutics Recent Developments and Future Plans
    2.4 Orphelia Pharma
        2.4.1 Orphelia Pharma Details
        2.4.2 Orphelia Pharma Major Business
        2.4.3 Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions
        2.4.4 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Orphelia Pharma Recent Developments and Future Plans
    2.5 Valerion Therapeutics
        2.5.1 Valerion Therapeutics Details
        2.5.2 Valerion Therapeutics Major Business
        2.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions
        2.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Valerion Therapeutics Recent Developments and Future Plans
    2.6 Catalyst Pharmaceuticals
        2.6.1 Catalyst Pharmaceuticals Details
        2.6.2 Catalyst Pharmaceuticals Major Business
        2.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
        2.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Catalyst Pharmaceuticals Recent Developments and Future Plans
    2.7 Anavex Life Sciences
        2.7.1 Anavex Life Sciences Details
        2.7.2 Anavex Life Sciences Major Business
        2.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions
        2.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Anavex Life Sciences Recent Developments and Future Plans
    2.8 Retrophin
        2.8.1 Retrophin Details
        2.8.2 Retrophin Major Business
        2.8.3 Retrophin Infantile Spasms Therapeutics Product and Solutions
        2.8.4 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Retrophin Recent Developments and Future Plans
    2.9 GW Pharmaceuticals
        2.9.1 GW Pharmaceuticals Details
        2.9.2 GW Pharmaceuticals Major Business
        2.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
        2.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 GW Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Infantile Spasms Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Infantile Spasms Therapeutics Players Market Share in 2021
        3.2.2 Top 10 Infantile Spasms Therapeutics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Infantile Spasms Therapeutics Players Head Office, Products and Services Provided
    3.4 Infantile Spasms Therapeutics Mergers & Acquisitions
    3.5 Infantile Spasms Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2017-2022)
    4.2 Global Infantile Spasms Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Infantile Spasms Therapeutics Revenue Market Share by Application (2017-2022)
    5.2 Global Infantile Spasms Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Infantile Spasms Therapeutics Revenue by Type (2017-2028)
    6.2 North America Infantile Spasms Therapeutics Revenue by Application (2017-2028)
    6.3 North America Infantile Spasms Therapeutics Market Size by Country
        6.3.1 North America Infantile Spasms Therapeutics Revenue by Country (2017-2028)
        6.3.2 United States Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        6.3.3 Canada Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Infantile Spasms Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Infantile Spasms Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Infantile Spasms Therapeutics Market Size by Country
        7.3.1 Europe Infantile Spasms Therapeutics Revenue by Country (2017-2028)
        7.3.2 Germany Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        7.3.3 France Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        7.3.5 Russia Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        7.3.6 Italy Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Infantile Spasms Therapeutics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Infantile Spasms Therapeutics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Infantile Spasms Therapeutics Revenue by Region (2017-2028)
        8.3.2 China Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        8.3.3 Japan Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        8.3.5 India Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        8.3.7 Australia Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Infantile Spasms Therapeutics Revenue by Type (2017-2028)
    9.2 South America Infantile Spasms Therapeutics Revenue by Application (2017-2028)
    9.3 South America Infantile Spasms Therapeutics Market Size by Country
        9.3.1 South America Infantile Spasms Therapeutics Revenue by Country (2017-2028)
        9.3.2 Brazil Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Infantile Spasms Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Infantile Spasms Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Infantile Spasms Therapeutics Revenue by Country (2017-2028)
        10.3.2 Turkey Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)
        10.3.4 UAE Infantile Spasms Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infantile Spasms Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Infantile Spasms Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Infantile Spasms Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Infantile Spasms Therapeutics Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Infantile Spasms Therapeutics Revenue Market Share by Region (2023-2028)
    Table 6. Mallinckrodt Corporate Information, Head Office, and Major Competitors
    Table 7. Mallinckrodt Major Business
    Table 8. Mallinckrodt Infantile Spasms Therapeutics Product and Solutions
    Table 9. Mallinckrodt Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. H. Lundbeck Corporate Information, Head Office, and Major Competitors
    Table 11. H. Lundbeck Major Business
    Table 12. H. Lundbeck Infantile Spasms Therapeutics Product and Solutions
    Table 13. H. Lundbeck Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Insys Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 15. Insys Therapeutics Major Business
    Table 16. Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions
    Table 17. Insys Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Orphelia Pharma Corporate Information, Head Office, and Major Competitors
    Table 19. Orphelia Pharma Major Business
    Table 20. Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions
    Table 21. Orphelia Pharma Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Valerion Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 23. Valerion Therapeutics Major Business
    Table 24. Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions
    Table 25. Valerion Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Catalyst Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 27. Catalyst Pharmaceuticals Major Business
    Table 28. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
    Table 29. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Anavex Life Sciences Corporate Information, Head Office, and Major Competitors
    Table 31. Anavex Life Sciences Major Business
    Table 32. Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions
    Table 33. Anavex Life Sciences Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Retrophin Corporate Information, Head Office, and Major Competitors
    Table 35. Retrophin Major Business
    Table 36. Retrophin Infantile Spasms Therapeutics Product and Solutions
    Table 37. Retrophin Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 39. GW Pharmaceuticals Major Business
    Table 40. GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
    Table 41. GW Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Global Infantile Spasms Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 43. Global Infantile Spasms Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 44. Breakdown of Infantile Spasms Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Infantile Spasms Therapeutics Players Head Office, Products and Services Provided
    Table 46. Infantile Spasms Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 47. Infantile Spasms Therapeutics New Entrants and Expansion Plans
    Table 48. Global Infantile Spasms Therapeutics Revenue (USD Million) by Type (2017-2022)
    Table 49. Global Infantile Spasms Therapeutics Revenue Share by Type (2017-2022)
    Table 50. Global Infantile Spasms Therapeutics Revenue Forecast by Type (2023-2028)
    Table 51. Global Infantile Spasms Therapeutics Revenue by Application (2017-2022)
    Table 52. Global Infantile Spasms Therapeutics Revenue Forecast by Application (2023-2028)
    Table 53. North America Infantile Spasms Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 54. North America Infantile Spasms Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 55. North America Infantile Spasms Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 56. North America Infantile Spasms Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 57. North America Infantile Spasms Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 58. North America Infantile Spasms Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 59. Europe Infantile Spasms Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 60. Europe Infantile Spasms Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 61. Europe Infantile Spasms Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 62. Europe Infantile Spasms Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 63. Europe Infantile Spasms Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 64. Europe Infantile Spasms Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 65. Asia-Pacific Infantile Spasms Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 66. Asia-Pacific Infantile Spasms Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 67. Asia-Pacific Infantile Spasms Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 68. Asia-Pacific Infantile Spasms Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 69. Asia-Pacific Infantile Spasms Therapeutics Revenue by Region (2017-2022) & (USD Million)
    Table 70. Asia-Pacific Infantile Spasms Therapeutics Revenue by Region (2023-2028) & (USD Million)
    Table 71. South America Infantile Spasms Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 72. South America Infantile Spasms Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 73. South America Infantile Spasms Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 74. South America Infantile Spasms Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 75. South America Infantile Spasms Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 76. South America Infantile Spasms Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 77. Middle East & Africa Infantile Spasms Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 78. Middle East & Africa Infantile Spasms Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 79. Middle East & Africa Infantile Spasms Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 80. Middle East & Africa Infantile Spasms Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 81. Middle East & Africa Infantile Spasms Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 82. Middle East & Africa Infantile Spasms Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Infantile Spasms Therapeutics Picture
    Figure 2. Global Infantile Spasms Therapeutics Revenue Market Share by Type in 2021
    Figure 3. Oral
    Figure 4. Injection
    Figure 5. Infantile Spasms Therapeutics Revenue Market Share by Application in 2021
    Figure 6. Hospital Picture
    Figure 7. Clinic Picture
    Figure 8. Other Picture
    Figure 9. Global Infantile Spasms Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 10. Global Infantile Spasms Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Infantile Spasms Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 12. Global Infantile Spasms Therapeutics Revenue Market Share by Region in 2021
    Figure 13. North America Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 14. Europe Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Asia-Pacific Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. South America Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Middle East and Africa Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Infantile Spasms Therapeutics Market Drivers
    Figure 19. Infantile Spasms Therapeutics Market Restraints
    Figure 20. Infantile Spasms Therapeutics Market Trends
    Figure 21. Mallinckrodt Recent Developments and Future Plans
    Figure 22. H. Lundbeck Recent Developments and Future Plans
    Figure 23. Insys Therapeutics Recent Developments and Future Plans
    Figure 24. Orphelia Pharma Recent Developments and Future Plans
    Figure 25. Valerion Therapeutics Recent Developments and Future Plans
    Figure 26. Catalyst Pharmaceuticals Recent Developments and Future Plans
    Figure 27. Anavex Life Sciences Recent Developments and Future Plans
    Figure 28. Retrophin Recent Developments and Future Plans
    Figure 29. GW Pharmaceuticals Recent Developments and Future Plans
    Figure 30. Global Infantile Spasms Therapeutics Revenue Share by Players in 2021
    Figure 31. Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 32. Global Top 3 Players Infantile Spasms Therapeutics Revenue Market Share in 2021
    Figure 33. Global Top 10 Players Infantile Spasms Therapeutics Revenue Market Share in 2021
    Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 35. Global Infantile Spasms Therapeutics Revenue Share by Type in 2021
    Figure 36. Global Infantile Spasms Therapeutics Market Share Forecast by Type (2023-2028)
    Figure 37. Global Infantile Spasms Therapeutics Revenue Share by Application in 2021
    Figure 38. Global Infantile Spasms Therapeutics Market Share Forecast by Application (2023-2028)
    Figure 39. North America Infantile Spasms Therapeutics Sales Market Share by Type (2017-2028)
    Figure 40. North America Infantile Spasms Therapeutics Sales Market Share by Application (2017-2028)
    Figure 41. North America Infantile Spasms Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 42. United States Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Infantile Spasms Therapeutics Sales Market Share by Type (2017-2028)
    Figure 46. Europe Infantile Spasms Therapeutics Sales Market Share by Application (2017-2028)
    Figure 47. Europe Infantile Spasms Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Infantile Spasms Therapeutics Sales Market Share by Type (2017-2028)
    Figure 54. Asia-Pacific Infantile Spasms Therapeutics Sales Market Share by Application (2017-2028)
    Figure 55. Asia-Pacific Infantile Spasms Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 56. China Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. South Korea Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Infantile Spasms Therapeutics Sales Market Share by Type (2017-2028)
    Figure 63. South America Infantile Spasms Therapeutics Sales Market Share by Application (2017-2028)
    Figure 64. South America Infantile Spasms Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 65. Brazil Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Argentina Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Type (2017-2028)
    Figure 68. Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Application (2017-2028)
    Figure 69. Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 70. Turkey Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Saudi Arabia Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. UAE Infantile Spasms Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals

Related Reports

Global Infantile Spasms Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Infantile Spasms Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Pharma & Healthcare

The Infantile Spasms Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Infantile Spasms Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Infantile Spasms Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

Global Infantile Spasms Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Infantile Spasms Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Infantile Spasms Therapeutics market size was valued at USD 146.1 million in 2023 and is forecast to a readjusted size of USD 185.2 million by 2030 with a CAGR of 3.4% during review period.

Global Infantile Spasms Therapeutics Supply, Demand and Key Producers, 2024-2030

Global Infantile Spasms Therapeutics Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Infantile Spasms Therapeutics market size is expected to reach $ 185.2 million by 2030, rising at a market growth of 3.4% CAGR during the forecast period (2024-2030).

Product Tags

infantile spasms therapeutics

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>